Sleeping for 7 hours and 18 minutes every night may be the sweet spot for warding off the risk of insulin resistance—the ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

The most recent version of NG28, the National Institute for Health and Care Excellence's (NICE) guidelines for managing type 2 diabetes in adults, has been released on February 18, 2026.

A recent study has found that 7 hours and 18 minutes may be the optimal amount of sleep you need each night to lower your ...

A meta-analysis shows GLP-1 RA therapy does not significantly lower vascular dementia events compared with placebo in high-risk patient groups.

Chinese scientists have achieved the world's first reversal of type-2 diabetes using stem-cell therapy. Here is what you need ...

Researchers from several partner institutions of the German Center for Diabetes Research (DZD) have collaborated with ...

Learn to manage type 2 diabetes while navigating early-stage Alzheimer's with expert advice on symptoms, simplified routines, and home safety strategies.

Eli Lilly and Company has reported detailed findings from the ACHIEVE-3 Phase III trial comparing the efficacy and safety of ...

Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...

Here’s something big: scientists in China have actually reversed type 2 diabetes using stem-cell therapy. It’s a major step ...